Identification and specificity of broadly neutralizing antibodies against HIV-Reference-Cited by-同舟云学术

Identification and specificity of broadly neutralizing antibodies against HIV

Published:2017-01 Issue:1 Volume:275 Page:11-20
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

McCoy Laura E.¹²,Burton Dennis R.¹³

Affiliation:

1. Department of Immunology & Microbial Science IAVI Neutralizing Antibody Center Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery The Scripps Research Institute La Jolla CA USA

2. Division of Infection & Immunity University College London London UK

3. Ragon Institute of Massachusetts General Hospital Massachusetts Institute of Technology and Harvard University Cambridge MA USA

Funder

International AIDS Vaccine Initiative

United States Agency for International Development

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.12484

Reference103 articles.

1. Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses

2. Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors

3. Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design

4. HIV-1 neutralizing antibodies: understanding nature's pathways

5. Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformations of membrane human immunodeficiency virus (HIV-1) envelope glycoproteins solubilized in Amphipol A18 lipid-nanodiscs;Journal of Virology;2024-09-09

2. A Mathematical Model Simulating the Adaptive Immune Response in Various Vaccines and Vaccination Strategies;2024-08-27

3. HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy;2024-07-12

4. Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs;iScience;2024-07

5. Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS;JCI Insight;2024-04-08